263 related articles for article (PubMed ID: 26640115)
1. Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair.
Nagalingam RS; Safi HA; Czubryt MP
J Mol Cell Cardiol; 2016 Apr; 93():108-14. PubMed ID: 26640115
[TBL] [Abstract][Full Text] [Related]
2. Heart repair by reprogramming non-myocytes with cardiac transcription factors.
Song K; Nam YJ; Luo X; Qi X; Tan W; Huang GN; Acharya A; Smith CL; Tallquist MD; Neilson EG; Hill JA; Bassel-Duby R; Olson EN
Nature; 2012 May; 485(7400):599-604. PubMed ID: 22660318
[TBL] [Abstract][Full Text] [Related]
3. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.
Qian L; Huang Y; Spencer CI; Foley A; Vedantham V; Liu L; Conway SJ; Fu JD; Srivastava D
Nature; 2012 May; 485(7400):593-8. PubMed ID: 22522929
[TBL] [Abstract][Full Text] [Related]
4. Direct reprogramming of fibroblasts into cardiomyocytes for cardiac regenerative medicine.
Fu JD; Srivastava D
Circ J; 2015; 79(2):245-54. PubMed ID: 25744738
[TBL] [Abstract][Full Text] [Related]
5. In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.
Mathison M; Singh VP; Chiuchiolo MJ; Sanagasetti D; Mao Y; Patel VB; Yang J; Kaminsky SM; Crystal RG; Rosengart TK
J Thorac Cardiovasc Surg; 2017 Feb; 153(2):329-339.e3. PubMed ID: 27773576
[TBL] [Abstract][Full Text] [Related]
6. In vivo reprogramming for heart regeneration: A glance at efficiency, environmental impacts, challenges and future directions.
Ebrahimi B
J Mol Cell Cardiol; 2017 Jul; 108():61-72. PubMed ID: 28502796
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function.
Jayawardena TM; Finch EA; Zhang L; Zhang H; Hodgkinson CP; Pratt RE; Rosenberg PB; Mirotsou M; Dzau VJ
Circ Res; 2015 Jan; 116(3):418-24. PubMed ID: 25351576
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
He WJ; Hou Q; Han QW; Han WD; Fu XB
Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
[TBL] [Abstract][Full Text] [Related]
9. Influence of mechanical stress on fibroblast-myocyte interactions in mammalian heart.
Abramochkin DV; Lozinsky IT; Kamkin A
J Mol Cell Cardiol; 2014 May; 70():27-36. PubMed ID: 24389344
[TBL] [Abstract][Full Text] [Related]
10. Conversion of human fibroblasts into functional cardiomyocytes by small molecules.
Cao N; Huang Y; Zheng J; Spencer CI; Zhang Y; Fu JD; Nie B; Xie M; Zhang M; Wang H; Ma T; Xu T; Shi G; Srivastava D; Ding S
Science; 2016 Jun; 352(6290):1216-20. PubMed ID: 27127239
[TBL] [Abstract][Full Text] [Related]
11. Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes.
Zhou H; Dickson ME; Kim MS; Bassel-Duby R; Olson EN
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11864-9. PubMed ID: 26354121
[TBL] [Abstract][Full Text] [Related]
12. Cardiac reprogramming: from mouse toward man.
Srivastava D; Berry EC
Curr Opin Genet Dev; 2013 Oct; 23(5):574-8. PubMed ID: 23993230
[TBL] [Abstract][Full Text] [Related]
13. Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage.
Isomi M; Sadahiro T; Fujita R; Abe Y; Yamada Y; Akiyama T; Mizukami H; Shu T; Fukuda K; Ieda M
Biochem Biophys Res Commun; 2021 Jun; 560():87-92. PubMed ID: 33984769
[TBL] [Abstract][Full Text] [Related]
14. Direct reprogramming of fibroblasts into cardiomyocytes.
Chen Y; Yang Z; Zhao ZA; Shen Z
Stem Cell Res Ther; 2017 May; 8(1):118. PubMed ID: 28545505
[TBL] [Abstract][Full Text] [Related]
15. Heart development and regeneration via cellular interaction and reprogramming.
Ieda M
Keio J Med; 2013; 62(4):99-106. PubMed ID: 24026008
[TBL] [Abstract][Full Text] [Related]
16. Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction.
Tani H; Sadahiro T; Yamada Y; Isomi M; Yamakawa H; Fujita R; Abe Y; Akiyama T; Nakano K; Kuze Y; Seki M; Suzuki Y; Fujisawa M; Sakata-Yanagimoto M; Chiba S; Fukuda K; Ieda M
Circulation; 2023 Jan; 147(3):223-238. PubMed ID: 36503256
[TBL] [Abstract][Full Text] [Related]
17. Chamber-Specific Protein Expression during Direct Cardiac Reprogramming.
Zhang Z; Villalpando J; Zhang W; Nam YJ
Cells; 2021 Jun; 10(6):. PubMed ID: 34208439
[TBL] [Abstract][Full Text] [Related]
18. Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.
Mohamed TM; Stone NR; Berry EC; Radzinsky E; Huang Y; Pratt K; Ang YS; Yu P; Wang H; Tang S; Magnitsky S; Ding S; Ivey KN; Srivastava D
Circulation; 2017 Mar; 135(10):978-995. PubMed ID: 27834668
[TBL] [Abstract][Full Text] [Related]
19. Turning fibroblasts into cardiomyocytes: technological review of cardiac transdifferentiation strategies.
Klose K; Gossen M; Stamm C
FASEB J; 2019 Jan; 33(1):49-70. PubMed ID: 30188756
[TBL] [Abstract][Full Text] [Related]
20. Chemical-induced cardiac reprogramming in vivo.
Huang C; Tu W; Fu Y; Wang J; Xie X
Cell Res; 2018 Jun; 28(6):686-689. PubMed ID: 29670223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
